Envoy Medical, Inc. (NASDAQ:COCH) Sees Large Increase in Short Interest

Envoy Medical, Inc. (NASDAQ:COCH) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 44,400 shares, an increase of 300.0% from the February 29th total of 11,100 shares. Approximately 0.7% of the company’s stock are sold short. Based on an average daily trading volume, of 400,100 shares, the short-interest ratio is presently 0.1 days.

Envoy Medical Stock Down 3.5 %

Shares of NASDAQ:COCH opened at $3.91 on Thursday. Envoy Medical has a 1 year low of $0.75 and a 1 year high of $11.72. The stock’s fifty day moving average price is $3.17.

Wall Street Analysts Forecast Growth

Separately, Northland Securities initiated coverage on Envoy Medical in a research report on Thursday, December 21st. They issued an “outperform” rating for the company.

Institutional Trading of Envoy Medical

A hedge fund recently bought a new stake in Envoy Medical stock. Weiss Asset Management LP acquired a new position in shares of Envoy Medical, Inc. (NASDAQ:COCH) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 20,000 shares of the company’s stock, valued at approximately $37,000. Weiss Asset Management LP owned approximately 0.10% of Envoy Medical at the end of the most recent quarter. Institutional investors and hedge funds own 8.59% of the company’s stock.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.